NEU neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1508

  1. 723 Posts.
    lightbulb Created with Sketch. 405


    Yesterday:


    https://investor.sagerx.com/news-re...cs-board-directors-initiates-review-strategic


    In addition, Sage announced that its Board has unanimously rejected the unsolicited, nonbinding proposal it received from Biogen Inc. (Nasdaq: BIIB) (“Biogen” on January 10, 2025, to acquire all outstanding shares of Sage not already owned by Biogen for $7.22 per share
    Last edited by Piton72: 29/01/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.18
Change
0.635(5.06%)
Mkt cap ! $1.640B
Open High Low Value Volume
$12.96 $14.00 $12.91 $17.54M 1.286M

Buyers (Bids)

No. Vol. Price($)
4 211 $13.16
 

Sellers (Offers)

Price($) Vol. No.
$13.18 7 1
View Market Depth
Last trade - 15.48pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.